FDA Inspection 1081769 — Apotex Research Private Limited
The FDA completed an inspection of Apotex Research Private Limited on February 2, 2019 in Bengaluru. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 2, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bengaluru (India)
Additional Details
Clinical BA/BE